Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma.

Literature DB >> 21594967

Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma.

Josep M Llovet¹, Valerie Paradis, Masatoshi Kudo, Jessica Zucman-Rossi.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2011 PMID： 21594967 PMCID： PMC3164216 DOI： 10.1002/lt.22340

Source DB: PubMed Journal: Liver Transpl ISSN： 1527-6465 Impact factor: 5.799

× No keyword cloud information.

39 in total

1. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.

Authors: Kazuaki Nakanishi; Michiie Sakamoto; Susumu Yamasaki; Satoru Todo; Setsuo Hirohashi
Journal: Cancer Date: 2005-01-15 Impact factor: 6.860

2. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Authors: Sandrine Boyault; David S Rickman; Aurélien de Reyniès; Charles Balabaud; Sandra Rebouissou; Emmanuelle Jeannot; Aurélie Hérault; Jean Saric; Jacques Belghiti; Dominique Franco; Paulette Bioulac-Sage; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal: Hepatology Date: 2007-01 Impact factor: 17.425

3. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.

Authors: Luca Di Tommaso; Giada Franchi; Young Nyun Park; Barbara Fiamengo; Annarita Destro; Emanuela Morenghi; Marco Montorsi; Guido Torzilli; Maurizio Tommasini; Luigi Terracciano; Luigi Tornillo; Raffaella Vecchione; Massimo Roncalli
Journal: Hepatology Date: 2007-03 Impact factor: 17.425

Review 4. Resection and liver transplantation for hepatocellular carcinoma.

Authors: Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal: Semin Liver Dis Date: 2005 Impact factor: 6.115

5. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors: Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal: N Engl J Med Date: 2005-10-20 Impact factor: 91.245

6. New strategies in hepatocellular carcinoma: genomic prognostic markers.

Authors: Augusto Villanueva; Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Clara Alsinet; Radoslav Savic; Helena Cornella; Josep M Llovet
Journal: Clin Cancer Res Date: 2010-08-16 Impact factor: 12.531

Review 7. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis.

Authors: M A Silva; B Hegab; C Hyde; B Guo; J A C Buckels; D F Mirza
Journal: Gut Date: 2008-07-31 Impact factor: 23.059

8. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.

Authors: Elisa Wurmbach; Ying-bei Chen; Greg Khitrov; Weijia Zhang; Sasan Roayaie; Myron Schwartz; Isabel Fiel; Swan Thung; Vincenzo Mazzaferro; Jordi Bruix; Erwin Bottinger; Scott Friedman; Samuel Waxman; Josep M Llovet
Journal: Hepatology Date: 2007-04 Impact factor: 17.425

9. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Authors: Taro Yamashita; Marshonna Forgues; Wei Wang; Jin Woo Kim; Qinghai Ye; Huliang Jia; Anuradha Budhu; Krista A Zanetti; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal: Cancer Res Date: 2008-03-01 Impact factor: 12.701

10. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.

Authors: Scott M Wilhelm; Christopher Carter; Liya Tang; Dean Wilkie; Angela McNabola; Hong Rong; Charles Chen; Xiaomei Zhang; Patrick Vincent; Mark McHugh; Yichen Cao; Jaleel Shujath; Susan Gawlak; Deepa Eveleigh; Bruce Rowley; Li Liu; Lila Adnane; Mark Lynch; Daniel Auclair; Ian Taylor; Rich Gedrich; Andrei Voznesensky; Bernd Riedl; Leonard E Post; Gideon Bollag; Pamela A Trail
Journal: Cancer Res Date: 2004-10-01 Impact factor: 13.312

9 in total

1. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.

Authors: Marcel C Langenbach; Thomas J Vogl; Isabelle von den Driesch; Benjamin Kaltenbach; Jan-Erik Scholtz; Renate M Hammerstingl; Tatjana Gruber-Rouh
Journal: Eur Radiol Date: 2019-06-24 Impact factor: 5.315

Review 2. Medical therapies for hepatocellular carcinoma: a critical view of the evidence.

Authors: Augusto Villanueva; Virginia Hernandez-Gea; Josep M Llovet
Journal: Nat Rev Gastroenterol Hepatol Date: 2012-11-13 Impact factor: 46.802

3. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors: Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal: Lancet Oncol Date: 2011-10-31 Impact factor: 41.316

4. Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma.

Authors: Tong-Chun Xue; Qing-An Jia; Ning-Ling Ge; Yi Chen; Bo-Heng Zhang; Sheng-Long Ye
Journal: Tumour Biol Date: 2015-06-10

Review 5. Liver transplantation for hepatocellular carcinoma: past, present and future.

Authors: Reza F Saidi; Seyed Kamran Hejazi Kenari
Journal: Middle East J Dig Dis Date: 2013-10

6. Peritumoral overexpression of ZBP-89 is associated with unfavorable disease-free survival rates in patients with hepatocellular carcinoma following hepatectomy.

Authors: Qiu-Shuang Wang; Chen Chen; Jing Zhan; Xie-Fan Fang; George G Chen; Sheng-Li Yang; Ren-Wang Chen; Fan Tong; Jian-Li Hu
Journal: Oncol Lett Date: 2018-03-26 Impact factor: 2.967